PENUMBRA INC

PEN stock refers to the publicly traded shares of Penumbra, Inc., a medical device company listed on the New York Stock Exchange under the ticker symbol PEN. The stock represents ownership in the company, which develops innovative healthcare technologies. Investors can find current price, volume, and other market data on the stock detail page for PEN.

Penumbra, Inc. designs, develops, and manufactures medical devices focused on interventional therapies for neurovascular and peripheral vascular conditions. Its products include aspiration systems, embolization coils, and other tools used in minimally invasive procedures. The company serves hospitals and healthcare providers, generating revenue primarily from device sales and related services.

Recent performance of PEN stock can be seen in the price chart and performance metrics on this page, which display changes over various periods such as daily, weekly, and year-to-date. For the most current price and percentage moves, please refer to the latest data shown at the top of the stock detail page.

Evaluating PEN's valuation involves examining metrics such as price-to-earnings (P/E) ratio, price-to-sales (P/S), and enterprise value-to-EBITDA, and comparing them to peers in the medical device industry. Growth prospects, profitability, and cash flow trends also matter. Current valuation metrics for PEN are available on the stock detail page.

PEN stock may trade in pre-market and after-hours sessions through certain brokers and electronic trading networks, though liquidity is typically lower and spreads wider than during regular NYSE hours. Extended-hours trading carries additional risks, such as price volatility and limited order types. Check with your brokerage for availability and specific session times.

Penumbra, Inc. does not currently pay a regular dividend. Instead, the company likely reinvests earnings into research, development, and growth initiatives. For the latest information on any dividend declarations or changes, please refer to the dividend section on the PEN stock detail page.